159 related articles for article (PubMed ID: 25325795)
1. Targeted delivery of anticancer agents via a dual function nanocarrier with an interfacial drug-interactive motif.
Zhang X; Huang Y; Zhao W; Liu H; Marquez R; Lu J; Zhang P; Zhang Y; Li J; Gao X; Venkataramanan R; Xu L; Li S
Biomacromolecules; 2014 Nov; 15(11):4326-35. PubMed ID: 25325795
[TBL] [Abstract][Full Text] [Related]
2. Improved Micellar Formulation for Enhanced Delivery for Paclitaxel.
Xu J; Zhang X; Chen Y; Huang Y; Wang P; Wei Y; Ma X; Li S
Mol Pharm; 2017 Jan; 14(1):31-41. PubMed ID: 28043124
[TBL] [Abstract][Full Text] [Related]
3. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.
Zhang X; Liu K; Huang Y; Xu J; Li J; Ma X; Li S
Bioconjug Chem; 2014 Sep; 25(9):1689-96. PubMed ID: 25121577
[TBL] [Abstract][Full Text] [Related]
4. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S
Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
[TBL] [Abstract][Full Text] [Related]
6. An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance.
Lu J; Zhao W; Liu H; Marquez R; Huang Y; Zhang Y; Li J; Xie W; Venkataramanan R; Xu L; Li S
J Control Release; 2014 Dec; 196():272-86. PubMed ID: 25456831
[TBL] [Abstract][Full Text] [Related]
7. PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
Zhang X; Huang Y; Zhao W; Chen Y; Zhang P; Li J; Venkataramanan R; Li S
Mol Pharm; 2014 Aug; 11(8):2807-14. PubMed ID: 24987803
[TBL] [Abstract][Full Text] [Related]
8. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma Immunochemotherapy: Targeted Delivery of Doxorubicin via a Dual Functional Nanocarrier.
Zhai Q; Chen Y; Xu J; Huang Y; Sun J; Liu Y; Zhang X; Li S; Tang S
Mol Pharm; 2017 Nov; 14(11):3888-3895. PubMed ID: 28850241
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier.
Zhang P; Lu J; Huang Y; Zhao W; Zhang Y; Zhang X; Li J; Venkataramanan R; Gao X; Li S
AAPS J; 2014 Jan; 16(1):114-24. PubMed ID: 24281690
[TBL] [Abstract][Full Text] [Related]
11. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.
Lu J; Huang Y; Zhao W; Marquez RT; Meng X; Li J; Gao X; Venkataramanan R; Wang Z; Li S
Biomaterials; 2013 Feb; 34(5):1591-600. PubMed ID: 23182923
[TBL] [Abstract][Full Text] [Related]
12. A PEG-Fmoc conjugate as a nanocarrier for paclitaxel.
Zhang P; Huang Y; Liu H; Marquez RT; Lu J; Zhao W; Zhang X; Gao X; Li J; Venkataramanan R; Xu L; Li S
Biomaterials; 2014 Aug; 35(25):7146-56. PubMed ID: 24856103
[TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
[TBL] [Abstract][Full Text] [Related]
15. Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy.
Zhang P; Li J; Ghazwani M; Zhao W; Huang Y; Zhang X; Venkataramanan R; Li S
Biomaterials; 2015 Oct; 67():104-14. PubMed ID: 26210177
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
17. Mixed micelles of TPGS and Soluplus
Wang Y; Ding Y; Xu Y; Wang C; Ding Y; Gao M; Ma C; Ma X; Li L
Pharm Dev Technol; 2020 Sep; 25(7):865-873. PubMed ID: 32266855
[TBL] [Abstract][Full Text] [Related]
18. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery.
Chen D; Yu H; Sun K; Liu W; Wang H
Drug Deliv; 2014 Jun; 21(4):258-64. PubMed ID: 24102086
[TBL] [Abstract][Full Text] [Related]
19. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS
J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818
[TBL] [Abstract][Full Text] [Related]
20. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
